Skip to content
Dose Brief
Menu
Head-to-head · Brief Score

CoreAge Rx vs System Labs

Two GLP-1 providers, one scoreboard. We put CoreAge Rx and System Labs head-to-head on the published Brief Score — the same six factors, scored the same way.

Higher Brief ScoreNo. 1 · Grade A

CoreAge Rx

Visit CoreAge Rx Full brief →
vs
No. 340 · Grade C

System Labs

Visit System Labs Full brief →

The verdict

CoreAge Rx takes this head-to-head.

CoreAge Rx scores 94 to 59 on our six-factor Brief Score — One price on both molecules that does not climb as you titrate — but the headline $99 and $149 are annual-plan rates, paid in full up front.

That doesn't make System Labs a bad call — it's best for readers who want one predictable tirzepatide bill they can cancel next month, and who will read the "/first mo." on the $99 before budgeting around it — not readers who came for semaglutide, or who need to confirm their state before starting an intake. Weigh the six factors below against your own priorities before you decide.

Why CoreAge Rx leads: it's our #1 here — one flat, no-step-up price on both molecules, nationwide, and the steadiest line on our tracker.

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.

Factor by factor

Both providers scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.

Price Stability
97
70
Supply Reliability
95
58
Transparency
90
54
Access Breadth
93
42
Clinical Oversight
92
70
Track Record
88
58
CoreAge RxBrief Score 94 · 59System Labs

Price, coverage & the tracker

CoreAge RxSystem Labs
Brief Score94/100 (A)59/100 (C)
Semaglutide$99/mo only on a 12-month plan paid in full ($1,188 in one charge); month-to-month rate not publishedNot offered — no semaglutide is sold here at any price
Tirzepatide$149/mo only on a 12-month plan paid in full ($1,788 in one charge); month-to-month rate not published$179/mo flat, month-to-month, the same at every dose — the $99 beside it is a first-month intro rate, not the ongoing one
CoverageUS only; restrictions by state, confirmed at intakeCoverage not published
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
On the trackerStableprice stableNewnew to the tracker, no prior reading

CoreAge Rx: Headline unchanged for a third straight cycle. The $99 and $149 are the 12-month prepay rates; CoreAge publishes no month-to-month price.

System Labs: First reading, 8 August 2026. One rate, one cadence: $179 a month, flat, month-to-month, identical at every dose — the FAQ commits to it in those words and the buy box sells a single "Monthly Supply (All doses)" line. No three-, six- or twelve-month rung exists, so there is no prepay figure here to mistake for a monthly one. The $99 printed beside it is a first-month intro rate, labeled "/first mo." on the page and flagged as an intro in the lander's own commerce data; month two is $179. Tirzepatide only — no semaglutide is sold at any price.

Keep comparing

Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.